Literature DB >> 8626905

MR-PET image coregistration for quantitation of striatal dopamine D2 receptors.

G J Wang1, N D Volkow, A V Levy, J S Fowler, J Logan, D Alexoff, R J Hitzemann, D J Schyler.   

Abstract

PURPOSE: Our goal was to assess the utility of MR-PET image coregistration to quantify dopamine D2 receptors in striatum.
METHOD: Twenty-nine normal subjects were investigated with PET and [11C]raclopride and with MRI. D2 receptors were quantified using the ratio of the distribution volume in striatum to that in cerebellum. Measures obtained using regions selected directly from the PET images were compared with those obtained from MR images and then projected to coregistered PET images.
RESULTS: There were no differences between measures selected from the PET images (3.9 +/- 0.5) and those from the MR images (3.9 +/- 0.65). The values for these two measures were significantly correlated and corresponded to r = 0.9, p < 0.0001.
CONCLUSION: Regions of interest selected directly from PET images, where there is a large contrast between the region of interest and background, as for the case of dopamine D2 ligands, are almost identical to those obtained from coregistered MR images.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626905     DOI: 10.1097/00004728-199605000-00020

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank W Telang; Joanna S Fowler; Jean Logan; Christopher T Wong; James M Swanson
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

2.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

3.  Dopaminergic activity in depressed smokers: a positron emission tomography study.

Authors:  Usoa E Busto; Laura Redden; Helen Mayberg; Shitij Kapur; Sylvain Houle; Laurie A Zawertailo
Journal:  Synapse       Date:  2009-08       Impact factor: 2.562

4.  Striatal dopamine and working memory.

Authors:  Susan M Landau; Rayhan Lal; James P O'Neil; Suzanne Baker; William J Jagust
Journal:  Cereb Cortex       Date:  2008-06-11       Impact factor: 5.357

5.  Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.

Authors:  Roshan Cools; Michael J Frank; Sasha E Gibbs; Asako Miyakawa; William Jagust; Mark D'Esposito
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

6.  Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis.

Authors:  Kao Chin Chen; Yen Kuang Yang; Oliver Howes; I Hui Lee; Sabine Landau; Tzung Lieh Yeh; Nan Tsing Chiu; Po See Chen; Ru Band Lu; Anthony S David; Elvira Bramon
Journal:  Schizophr Bull       Date:  2011-12-08       Impact factor: 9.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.